Literature DB >> 8466481

Dopamine D1 receptor mutagenesis: role of amino acids in agonist and antagonist binding.

M Tomic1, P Seeman, S R George, B F O'Dowd.   

Abstract

We investigated the role of amino acids, by site-directed mutagenesis, in five of the seven transmembrane regions of the human dopamine D1 receptor. The results demonstrate a role for an aspartic acid (Asp70) in transmembrane 2 mediating the sodium ion effect on receptor conformation. Amino acids residues in transmembrane 3 and 5 are important for optimum dopamine binding to the receptor. Mutant receptors involving amino acids in transmembrane 7 suggest that binding sites for agonists and antagonists have distinct binding determinants within the dopamine D1 receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8466481     DOI: 10.1006/bbrc.1993.1319

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonists.

Authors:  Lisa A Bonner; Benjamin R Chemel; Val J Watts; David E Nichols
Journal:  Bioorg Med Chem       Date:  2010-07-27       Impact factor: 3.641

2.  Dynamic modelling of the binding of substances to the conserved membrane-adjacent heptapeptide of the 15-residue C-terminal cytoplasmic fragment of mammalian dopamine D2 receptors.

Authors:  E Roberts; J Wendel
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

3.  Functional roles of T3.37 and S5.46 in the activation mechanism of the dopamine D1 receptor.

Authors:  Estefanía A Hugo; Bruce K Cassels; Angélica Fierro
Journal:  J Mol Model       Date:  2017-03-31       Impact factor: 1.810

4.  Mapping the catechol binding site in dopamine D₁ receptors: synthesis and evaluation of two parallel series of bicyclic dopamine analogues.

Authors:  Lisa A Bonner; Uros Laban; Benjamin R Chemel; Jose I Juncosa; Markus A Lill; Val J Watts; David E Nichols
Journal:  ChemMedChem       Date:  2011-04-28       Impact factor: 3.466

5.  Ligand-specific roles for transmembrane 5 serine residues in the binding and efficacy of dopamine D(1) receptor catechol agonists.

Authors:  Benjamin R Chemel; Lisa A Bonner; Val J Watts; David E Nichols
Journal:  Mol Pharmacol       Date:  2012-02-14       Impact factor: 4.436

6.  Homology modeling of the human 5-HT1A, 5-HT 2A, D1, and D2 receptors: model refinement with molecular dynamics simulations and docking evaluation.

Authors:  Beow Keat Yap; Michael J C Buckle; Stephen W Doughty
Journal:  J Mol Model       Date:  2012-02-22       Impact factor: 1.810

7.  The genetic effects of the dopamine D1 receptor gene on chicken egg production and broodiness traits.

Authors:  Haiping Xu; Xu Shen; Min Zhou; Meixia Fang; Hua Zeng; Qinghua Nie; Xiquan Zhang
Journal:  BMC Genet       Date:  2010-03-03       Impact factor: 2.797

8.  Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.

Authors:  Wei Fu; Jianhua Shen; Xiaomin Luo; Weiliang Zhu; Jiagao Cheng; Kunqian Yu; James M Briggs; Guozhang Jin; Kaixian Chen; Hualiang Jiang
Journal:  Biophys J       Date:  2007-04-27       Impact factor: 4.033

9.  Investigation of D₁ receptor-agonist interactions and D₁/D₂ agonist selectivity using a combination of pharmacophore and receptor homology modeling.

Authors:  Marcus Malo; Lars Brive; Kristina Luthman; Peder Svensson
Journal:  ChemMedChem       Date:  2012-02-07       Impact factor: 3.466

10.  In Vitro and In Silico Characterization of Kurarinone as a Dopamine D1A Receptor Antagonist and D2L and D4 Receptor Agonist.

Authors:  Ritu Prajapati; Su Hui Seong; Pradeep Paudel; Se Eun Park; Hyun Ah Jung; Jae Sue Choi
Journal:  ACS Omega       Date:  2021-12-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.